In addition, there were some clinicopathological markers such as the Gleason score, clinical stage and PSA levels which were also applied to predict BCR following local PCa treatment (Cornford et al., 2017; D’Andrea et al., 2018). The gene discussed is BCR; the disease is posterior cortical atrophy.